1150P Search for biomarkers to personalize treatment with streptozotocin plus 5-fluorouracil or everolimus in patients with advanced pancreatic neuroendocrine tumors: The randomized phase III SEQTOR trial (GETNE-1206)
| Autor: | Salazar Soler, R., Scarpa, A., Lawlor, R.T., Sadanandam, A., Tafuto, S., Krogh, M., Teule, A., Garcia-Carbonero, R., Klumpen, H.J., Cremer, B., Sevilla, I., Eriksson, B.K., Mitkina Tabaksblat, E., Metges, J-P., Reed, N.S., Schrader, J., Bozzarelli, S., Venerito, M., Navarro, V., Capdevila Castillon, J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S754-S754 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|